505 COAST BOULEVARD SOUTH, LA JOLLA, CA
Board Expansion - Evgeny Zaytsev Appointed as Class I Director
CalciMedica, Inc. Enters First Amendment to Loan Agreement for $10M
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Financial Results, Press Release
Other Events
Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation
Q1
Amended Annual Report
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
Amended Schedule 13D - Ownership Report
S-8 POS